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BLNK Required for Coupling Syk to PLCg2
and Rac1-JNK in B Cells
understanding the details of BCR-mediated signal trans-
duction.
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al., 1996; Harmer and DeFranco, 1997). Thus, upon BCR
Summary stimulation, the SH2 domain of Grb2 is thought to inter-
act with tyrosine-phosphorylated membrane proteins,
Signaling through the B cell receptor (BCR) is essential thereby bringing Sos to the plasma membrane.
for B cell function and development. Despite the key While much has been learned as to the relationship
role of Syk in BCR signaling, little is known about between the BCR-associated PTKs and downstream
the mechanism by which Syk transmits downstream effectors, the molecular mechanism by which these
effectors. BLNK (B cell LiNKer protein), a substrate PTKs regulate downstream events remains unclear.
for Syk, is now shown to be essential in activating Analogous to receptor tyrosine kinases (Pawson and
phospholipase C (PLC)g2 and JNK. The BCR-induced Schlessinger, 1993), it has been thought that many sig-
PLCg2 activation, but not the JNK activation, was naling molecules directly bind phosphorylated tyrosine
restored by introduction of PLCg2 membrane-asso- residues on the cytoplasmic domains of Iga and Igb
ciated form into BLNK-deficient B cells. As JNK ac- and/or on the BCR-associated PTKs. However, this does
tivation requires both Rac1 and PLCg2, our results not appear to be a feature of the coupling mechanism
suggest that BLNK regulates the Rac1-JNK pathway, to downstream signaling pathways. Attention instead
in addition to modulating PLCg2 localization. has focused on adaptor proteins, one of which is BLNK
(alternatively named SLP-65) (Fu and Chan, 1997; Fu et
al., 1998; Wienands et al., 1998). BLNK is a B cell±Introduction
specific protein that is phosphorylated by Syk after BCR
ligation. BLNK, like SLP-76 (Jackman et al., 1995), com-B cell receptor (BCR) engagement triggers complex cas-
prises a COOH-terminal SH2 domain, a central proline-cades of biochemical events that culminate in gene tran-
rich region that binds to Grb2 SH3 domains, and multiplescription, cellular proliferation, and differentiation. The
tyrosine phosphorylation sites.BCR utilizes sequential activation of at least three types
We have investigated the mechanisms by which Sykof cytoplasmic protein tyrosine kinases (PTKs), Src-PTK,
mediates downstream effectors in B cells. Since BLNKSyk, and Btk to regulate downstream effectors. Deficien-
interacts with a variety of downstream effector proteinscies of these three families of PTKs result in defective
including PLCg2, Vav, Grb2, and Nck (Fu and Chan,or aberrant B cell function and development (Pleiman
1997; Fu et al., 1998; Wienands et al., 1998), we hypothe-et al., 1994; DeFranco, 1997; Kurosaki, 1997; Reth and
sized that BLNK functions as a master substrate to inter-Wienands, 1997). Thus, characterization of the sub-
face Syk with multiple downstream effectors. We nowstrates of these activated PTKs is a prerequisite for
report the consequences of disruption of BLNK on the
BCR-mediated responses and demonstrate a critical
role for BLNK in activation of PLCg2 and Rac1-JNK, but‖ To whom correspondence should be addressed (e-mail: kurosaki@
mxr.meshnet.or.jp). not Ras.
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Figure 1. The Gene for Chicken pp80 Encodes BLNK
(A) Alignment of the BLNK protein. The sequences of chicken (longer form), human (longer form; pp70) (Fu et al., 1998), and mouse (Fu et al.,
1998) were aligned by the Clustal W program (Thompson et al., 1994). Identical amino acids are indicated by the box. The shorter form of
chicken BLNK lacks 20 amino acids (positions 38±57). Peptide sequences obtained from microsequences were as follows (amino acid number):
LAVPAGEK (7±14), KPPPSLPRR (61±69), DNRTSHHQ (140±147), VPEAPSRAL (408±416), AWYAATCDRK (441±450), DGSFLIRK (462±469),
CGEERFDSVAEIVEN (510±524). (B) Schematic diagrams of human and chicken BLNK. Structural domains of BLNK are shown.
Results BLNK Is Required for BCR-Induced
PLCg2 Activation
To address the function of BLNK, we established DT40Chicken pp80 That Is Tyrosine Phosphorylated
B cells deficient in BLNK by gene-targeting method.by BCR Ligation Is BLNK
Lack of BLNK expression was confirmed by NorthernOur previous studies have shown that BCR-evoked
and Western analyses (Figures 2A and 2B). The level ofPLCg2 activation is a downstream event of Syk in DT40
cell surface expression of BCR on BLNK-deficient DT40B cells (Takata et al., 1994). These genetic data, how-
clone was essentially the same as that of parentalever, do not necessarily indicate that PLCg2 is directly
DT40 cells (Figure 2C). Transcript of chicken SLP-76 inregulated by Syk in B cells. Indeed, while Syk can phos-
DT40 cells could not be detected by RT-PCR methodphorylate PLCg1 in COS cells (Law et al., 1996), expres-
(data not shown).sion of a functional BCR, Fyn, and Syk in non-lymphoid
Comparison of the BCR-induced overall tyrosinecells does not induce PLCg phosphorylation or in-
phosphorylation between wild-type and BLNK-deficientcreased intracellular Ca21 ([Ca21]i) upon receptor stimu-
DT40 cells did not exhibit significant changes, exceptlation (Richards et al., 1996). These reconstitution stud-
that the band corresponding to BLNK itself was absenties suggest the existence of B cell±specific protein(s)
in the mutant cells (Figure 2D). These results suggestthat may link Syk with PLCg2 activation. Thus, we puri-
that the BCR-associated PTKs such as Lyn and Syk arefied tyrosine-phosphorylated proteins from activated
activated normally in the absence of BLNK.DT40 cells by affinity purification protocol based on their
One of the hallmarks of the BCR-induced signalingability to bind an anti-phosphotyrosine MAb.
is calcium mobilization. Fura 2-loaded wild-type andAmong several purified proteins, four internal peptide
BLNK-deficient DT40 cells were stimulated with anti-sequences obtained from microsequencing of pp80
BCR MAb, M4, and the rise of [Ca21]i was measured.were very homologous to those of human and mouse
As shown in Figure 3A, no increase in [Ca21]i was de-BLNK (Figure 1A). A chicken cDNA was cloned by com-
tected in BLNK-deficient cells. Consistent with the cal-bination of RT-PCR method and library screening (see
cium defect, BLNK-deficient DT40 cells abolished theExperimental Procedures). Two PCR products that dif-
tyrosine phosphorylation of PLCg2 (Figure 3C), resultingfered by the presence of the insertion of 20 amino acids
in the loss of IP3 generation (Figure 3B) upon receptorat their N termini were detected (Figure 1 legend). Both
stimulation. These defects were restored by reexpres-forms contain all of the tyrosine phosphorylation sites,
sion of chicken BLNK (longer form) in the BLNK-deficientthe proline-rich domain, and the C-terminal SH2 domain,
similar to human and mouse BLNK (Figure 1B). Thus, cells (Figures 2B, 3A, 3B, and 3C). These data indicate
that BLNK is required for coupling Syk to PLCg2 activa-we conclude that pp80 phosphoprotein is a chicken
homolog of BLNK. tion in DT40 B cells.
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1998). Because PLCg2 associates with BLNK in a recep-
tor ligation-dependent fashion, we examined the trans-
location of PLCg2 to the membrane fraction upon BCR
aggregation in wild-type and BLNK-deficient B cells.
While the stoichiometry of membrane-associated PLCg2
was substantially enhanced following BCR ligation in
wild-type DT40 cells, the translocation of PLCg2 to the
membrane fraction was markedly attenuated in BLNK-
deficient cells (Figure 3E).
The above observations suggest that PLCg2, when
associated with the plasma membrane by virtue of
BLNK, gains susceptibility to tyrosine phosphorylation
and/or access to its substrate phosphatidylinositol 4,5-
bisphosphate (PI 4,5-P2), which in turn generates IP3 and
DAG. This hypothesis predicts that the calcium defect
in BLNK-deficient cells should be suppressible by mem-
brane expression of PLCg2. To test this prediction, a
chimera possessing the catalytic domains of PLCg2 in
place of the cytoplasmic domain of FcgRIII (mPLCg2
shown in Figure 4A) was expressed in BLNK-deficient
DT40 cells. Stimulation of the chimeric receptor alone
did not induce calcium mobilization (data not shown).
Although BCR ligation alone induced a small [Ca21]i in-
crease, coligation of the BCR to the FcgRIII/PLCg2 chi-
mera resulted in a substantial [Ca21]i increase (Figure
4B). This [Ca21]i increase was more susutained than that
upon BCR engagement in wild-type DT40 cells (Figure
3A), suggesting that dissociation of native PLCg2 from
the membrane fraction is likely required for the proper
termination of a [Ca21]i increase initiated by BCR li-
gation.
As shown in Figure 4C, the anti-PLCg2 Ab recognized
Figure 2. Disruption of the BLNK Gene in Chicken DT40 B Cells
two species of FcgRIII/PLCg2, presumably reflecting
(A) Northern blot analysis of BLNK RNA expression. RNAs prepared posttranslational modifications of this molecule. As ex-from wild-type and BLNK-deficient DT40 cells were separated in
pected, coligation of the chimeric receptor and BCR1.2% formaldehyde gel, blotted, and probed with 32P-labeled cDNAs
induced tyrosine phosphorylation of FcgRIII/PLCg2, thechicken BLNK (top) or b-actin (bottom). The positions of the 28S
and 18S rRNA are shown. upper one of which was more prominent. Collectively,
(B) Protein expression analysis of BLNK. Total cell lysate (2.5 3 106 these results indicate that membrane expression of
cells) were prepared and analyzed by Western blotting using anti- PLCg2 is sufficient to overcome the inhibition of PLCg2
BLNK Ab. Transformant of chicken BLNK cDNA (longer form) into activation observed in BLNK-deficient cells.BLNK-deficient DT40 cells is indicated as BLNK/BLNK2.
(C) Cell surface expression of BCR on wild-type and mutant cells.
Unstained cells were used as negative controls (dot lines).
Ras Activation Still Occurs in the Absence(D) Tyrosine phosphorylation in wild-type and BLNK-deficient DT40
cells. At the indicated time points after stimulation with M4 (4 mg/ of BLNK
ml), whole-cell lysates prepared from 2.5 3 106 cells were loaded Because the BCR-induced ERK activation is also a
onto SDS-PAGE (8% gel) and analyzed by Western blotting with downstream event of Syk in DT40 B cells (Jiang et al.,
anti-phosphotyrosine Ab (4G10). 1998), we examined the effect of BLNK on ERK2 activa-
tion. BLNK-deficient cells exhibited barely detectable
ERK2 activation at 1 min after BCR stimulation, while this
To formally demonstrate that BLNK acts upstream to activation was observed at 3 min despite less effectively
PLCg2 activation in the context of BCR signaling, we than wild-type cells. In contrast to the inhibition of the
examined the effect of disruption of PLCg2 on BLNK ERK2 response in the absence of BLNK, Syk-deficient
phosphorylation. Immunoprecipitation of BLNK from DT40 cells showed the complete abrogation of the ERK2
wild-type and PLCg2-deficient DT40 cells demonstrated response, as reported previously (Jiang et al., 1998) (Fig-
comparable levels of BLNK phosphorylation following ure 5A).
BCR ligation (Figure 3D). Hence, tyrosine phosphoryla- As both PLCg2 and Ras pathways contribute to ERK2
tion of BLNK by Syk likely lies upstream to that of PLCg2. activation in DT40 cells (Hashimoto et al., 1998), we
investigated the mechanism by which BLNK regulates
ERK2. To directly determine whether BLNK affects RasExpression of PLCg2 As a Membrane Chimera
in BLNK-Deficient Cells Restored activation, we employed a binding assay developed by
Taylor and Shalloway (1996). This assay is based on theCalcium Mobilization
It has been previously shown that BLNK is translocated observation that Raf protein has high affinity for active
Ras-GTP but does not bind the inactive GDP-boundto the membrane fraction upon BCR ligation (Fu et al.,
Immunity
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Figure 3. Characterization of BLNK-Deficient
DT40 Cells
(A) Calcium mobilization analysis. Intracellu-
lar free calcium levels in Fura-2-loaded cells
were monitored by a spectrophotometer after
stimulation with M4 (2 mg/ml). Arrows indicate
the time point for adding M4 Ab.
(B) BCR-induced IP3 generation. Cells (2 3
106) were stimulated with MAb M4 (10 mg)
for indicated time, and IP3 productions were
measured. Data are shown as fold increase
of the value before stimulation with M4.
(C) Tyrosine phosphorylation of PLCg2. At the
indicated time points after M4 stimulation (4
mg/ml), immunoprecipitates with anti-PLCg2
Ab (1 3 107 cells/lane) were separated on
7% SDS-PAGE gel and analyzed by Western
blotting with 4G10 (upper). The same filter
was reprobed with anti-PLCg2 Ab (bottom).
(D) Analysis of BLNK phosphorylation in wild-
type and PLCg2-deficient DT40 cell. Cells
(5 3 106 cells/lane) were similarly analyzed as
in (C) using anti-BLNK Ab and 8% SDS-PAGE
gel.
(E) Subcellular analysis of PLCg2. Wild-type
and BLNK-deficient DT40 cells were stimu-
lated by M4 for 3 min (1) or left unstimulated
(-). Membrane fractions were analyzed by
Western blotting with anti-PLCg2 Ab (upper)
and anti-Lyn Ab (bottom).
form of Ras. BCR crosslinking of wild-type and BLNK- BLNK Is Required for the Rac1-JNK Pathway
JNK and p38 responses require Rac1, in addition todeficient cells both resulted in increased Ras-GTP,
though the fold increase observed in the BLNK-deficient PLCg2 activation. In fact, either expression of a domi-
nant-negative form of Rac1 or loss of PLCg2 almostcells was somewhat lower than that in wild-type cells
(Figure 5B). Hence, the significant attenuation in ERK2 completely abolishes the BCR-mediated activation of
JNK and p38 (Hashimoto et al., 1998). Thus, to examineactivation in BLNK-deficient cells could not be ac-
counted for by the defect of Ras activation in the mutant the role of BLNK in a Rac1-dependent pathway, we
analyzed JNK and p38 responses in wild-type andcells.
In order to test whether the defect in ERK2 activation BLNK-deficient DT40 cells. As shown in Figure 6, BCR-
mediated activation of both JNK and p38 was com-by loss of BLNK was due to a defect in the PLCg2-
mediated signaling, we examined whether or not coliga- pletely abrogated in BLNK-deficient DT40 cells. Using
a similar approach for exploring the contribution oftion of BCR and FcgRIII/PLCg2 in BLNK-deficient cells
overcomes the ERK2 inhibition. BCR-ligation alone PLCg2 to ERK2 activation, we determined whether coli-
gation of BCR and FcgRIII/PLCg2 can restore the JNKshowed a similar degree of inhibition in ERK2 activation
(data not shown), while BCR-mediated ERK2 activation and p38 responses in BLNK-deficient cells. In contrast
to restoration of the ERK2 response by coligation ofwas restored in the mutant cells after coligation of these
receptors (Figure 5A), indicating that PLCg2 activation BCR and FcgRIII/PLCg2 (Figure 5A), coligation of these
receptors was unable to restore the BCR-mediated acti-is sufficient to restore the ERK2 response in the absence
of BLNK. Together, these data demonstrate that the vation of both JNK and p38. Thus, we conclude that
loss of BLNK affects not only the PLCg2 pathway butattenuation in ERK2 activity observed in the BLNK-defi-
cient cells is likely due to a defect in PLCg2-dependent also the Rac1-dependent pathway.
contribution to ERK2 activation. While the effect on
ERK2 activation by BLNK was primarily mediated through
PLCg2, Ras undoubtedly also contributes to full ERK2 Discussion
activity, as expression of a dominant-negative form of
Ras (RasN17) completely abolished the residual ERK2 A striking feature of BCR signaling is that a variety of
distinct signaling pathways become activated by multi-activity observed in BLNK-deficient cells (Figures 5A
and 5C). ple cytoplasmic PTKs (DeFranco, 1997). Thus, one of
Function of BLNK in BCR Signaling
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Figure 4. Expression of Membrane-Local-
ized PLCg2 Suppresses BLNK Inhibition
(A) Schematic diagram of membrane PLCg2
chimera (mPLCg2). This is composed of
the extracellular domain of human FcgRIIIA
(amino acids 1±212) (Ravetch and Perussia,
1989), the transmembrane domain of the hu-
man T cell receptor z chain (amino acids 30±
58) (Weissman et al., 1988), and the complete
rat PLCg2 (Emori et al., 1989) as a cyto-
plasmic domain.
(B) Calcium mobilization after coligation of
BCR and membrane PLCg2 chimera. For coli-
gation, rabbit anti-mouse IgM was added
prior to stimulation with M4. Arrow indicates
the addition of M4. Surface expression level
of FcgRIII is indicated in an inset box.
(C) BCR-induced tyrosine phosphorylation
of mPLCg2 in BLNK-deficient DT40 cells.
After coligation, immunoprecipitates with
anti-PLCg2 Ab were analyzed by Western
blotting with 4G10 (upper) or anti-PLCg2 Ab
(bottom).
the key questions is the mechanism by which the BCR- data shown in Figures 3C and 3D indicate that tyrosine
phosphorylation of BLNK by Syk is an upstream eventactivated PTKs activate the appropriate subset of sig-
naling pathways within the cell. In the case of Syk, at to PLCg2 phosphorylation. Thus, these findings suggest
that the phosphorylated BLNK brings PLCg2 into closeleast three signaling pathways (PLCg2, Ras, and Rac1-
JNK) have been identified as its downstream effectors proximity with the activated Syk and thereby facilitates
the tyrosine phosphorylation and subsequent activation(Takata et al., 1994; Hashimoto et al., 1998; Jiang et al.,
1998). In this study, we provide genetic evidence that of PLCg2. Consistent with this model, a membrane chi-
mera FcgRIII/PLCg2 was able to overcome the defectsBLNK functions as a coupling molecule to PLCg2 and
Rac1 pathways, but not to the Ras pathway. of PLCg2 phosphorylation and its subsequent activation
observed in BLNK-deficient cells, when cross-linked toA model for the mechanism of BLNK-mediated activa-
tion of PLCg2, based on the data presented here, is the BCR (Figure 4). The observation that the BCR-medi-
ated translocation of PLCg2 to the membrane fractionshown in Figure 7. Previous studies have shown that
Syk is essential for tyrosine phosphorylation of both is inhibited by loss of BLNK (Figure 3E), together with
the evidence of colocalization of BLNK with Syk (C. F.BLNK and PLCg2 upon BCR engagement, since Syk-
deficient DT40 cells fail to phosphorylate these mole- and A. C. C., unpublished data), further supports this
model.cules (Takata et al., 1994; Fu et al., 1998). In addition, the
Figure 5. ERK2 Responses upon BCR En-
gagement
(A) Various DT40 cells were stimulated with
M4 (4 mg/ml) for indicated time. For mPLCg2/
BLNK2, cells were incubated with anti-mouse
IgM (10 mg/ml) for 5 min before M4 simulation.
ERK2 was immunoprecipitated and the pre-
cipitates were assayed for kinase activity us-
ing GST-Elk1 fusion protein as a substrate.
The kinase reaction products were resolved
by 12.5% SDS-PAGE gel and autoradiogra-
med. The protein levels in immunoprecipi-
tates by Western blot analysis were shown in
a lower panel.
(B) Analysis of Ras activation by the Ras-GTP
method. M4 stimulated cell lysates were sub-
jected to affinity precipitation with GST-RBD.
Activated Ras proteins were detected by
Western blotting with anti-Ras Ab (upper).
Similarly, the total amount of Ras protein was
determined using the cell lysate (bottom).
(C) Ras protein expression in BLNK-deficient
cells expressing RasN17. Expression was
measured by Western blot analysis using
anti-Ras Ab.
Immunity
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we propose that after PLCg2 is recruited to the mem-
brane fraction by BLNK, the membrane-associated Btk
is then able to phosphorylate tyrosine residues on
PLCg2, leading to its full activation. Since Btk SH2 do-
main, in addition to its PH domain, is required for full
PLCg2 phosphorylation in B cells (Takata and Kurosaki,
1996), Btk SH2 domain might be recruited to tyrosine-
phosphorylated BLNK, allowing Btk to phosphorylate
PLCg2.
As BLNK is structurally related to SLP-76, BLNK likely
plays a functionally similar role in B cells as SLP-76
plays in T cells. The calcium defect observed in the SLP-
76-deficient Jurkat T cell line (Yablonski et al., 1998),
however, is not so complete as the phenotype observed
in the BLNK-deficient DT40 B cells. This difference may
be due to the residual expression of SLP-76 in the mu-
tant Jurkat cell line, as mentioned in their report. Another
possibility is that LAT, which is expressed in T but not
in B cells (Weber et al., 1998; Zhang et al., 1998), cooper-
ates with SLP-76 in regulating the calcium signaling
pathway. Thus, in the case of T cells, the existence of
LAT may rescue the calcium defect to some extent even
in the absence of SLP-76. Additional studies are under-
way to further define the functional parallels between
the use of these adaptor proteins in T and B cells.
We have previously shown that the synergistic actionFigure 6. BCR-Induced JNK and p38 Activation in BLNK-Deficient
of Ras and PLCg2 pathways is required for BCR-inducedDT40 Cells
ERK2 response in DT40 cells. The ERK2 response isStimulation was carried out as in Figure 5A. After M4 (4 mg/ml)
partially blocked by loss of PLCg2 or expression ofstimulation cell lysates were immunoprecipitated with anti-JNK1 (A)
and anti-p38 Ab (B), kinase activities were assayed as in Figure 5A RasN17, while this response is completely abrogated by
using GST-c-Jun and GST-ATF2 as substrates, respectively. introduction of RasN17 into the PLCg2-deficient mutant
(Hashimoto et al., 1998). Thus, the partial inhibition of
BCR-mediated ERK2 response in BLNK-deficient DT40
Btk, in addition to Syk, has been shown to be required cells can be accounted for by the defect of PLCg2 path-
for maximum tyrosine phosphophorylation of PLCg2 way in this mutant cell. This explanation is supported
upon antigen receptor engagement and its full activation by (1) Ras activation even in the absence of BLNK, as-
(Takata and Kurosaki, 1996; Fluckiger et al., 1998). Since sessed by binding to GST-Raf; (2) complete inhibition
BCR-induced tyrosine phosphorylation of BLNK nor- of the ERK2 response by the introduction of RasN17
into the mutant cells; and (3) restoration of the ERK2mally occurs in Btk-deficient DT40 cells (Fu et al., 1998),
Figure 7. Model for the Mechanism of BLNK-
Mediated PLCg2 Activation upon BCR Stimu-
lation
Upon BCR engagement, activated Syk phos-
phorylates BLNK, leading to its translocation
to the membrane. Phosphorylated BLNK
brings PLCg2 into the close proximity with
the activated Syk in the membrane, thereby
facilitating tyrosine phosphorylation of PLCg2
by Syk. Membrane-localized Btk, presumably
due to interaction between its PH domain and
PI 3,4,5-P3 (Salim et al., 1996; Rameh et al.,
1997; Bolland et al., 1998; Fluckiger et al.,
1998), further phosphorylates other tyrosine
residues on PLCg2, resulting in its full activa-
tion. Activated PLCg2 hydrolyzes PI 4,5-P2
leading to the generation of second messen-
gers, IP3 and DAG.
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PLCg2 chimera cDNA (mPLCg2 in Figure 4A) was constructed byresponse by coligation of BCR and FcgRIII/PLCg2 chi-
using PCR method and cloned into pApuro. The cDNA of RasN17mera in the mutant cells. Given the evidence that translo-
in pApuro vector was already described (Hashimoto et al., 1998).cation of Grb2 from the cytoplasmic to the membrane
These cDNAs were transfected by electroporation at 550 V, 25 mF,
fraction is critical for Ras activation in B cells (Hashimoto and selected in the presence of 0.5 mg/ml puromycin (Sigma). Ex-
et al., 1998), our data suggest that BLNK is not necessar- pression of transfected cDNA was confirmed by Western blot analy-
ily required for recruitment of Grb2 to the membrane sis or FACS analysis (mPLCg2). Cell surface expression of BCR and
FcgRIII were analyzed by FACScan (Becton Dickinson) using FITC-fraction. Instead, Grb2 might be recruited to another
conjugated anti-chicken IgM or FITC-conjugated anti-human FcgRIIIlinking molecule, tyrosine phosphorylation of which is
Ab, respectively. The x and y axes for the histograms indicate fluo-mediated presumably by Syk, since BCR-induced ERK2
rescence intensity (4-decade-log scales) and relative cell number,response is completely abrogated in Syk-deficient DT40
respectively.
cells (Jiang et al., 1998) (Figure 5).
BLNK-deficient cells were unable to activate JNK or Purification of Chicken pp80
p38 following BCR ligation. Moreover, coligation of DT40 cells (1.5 3 1010) were stimulated for 3 min at 2 3 107 cells/
ml in RPMI 1640 with M4 (3 mg/ml) at 378C. Cells were solubilizedthe BCR and the FcgRIII/PLCg2, while sufficient to re-
in 20 ml NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 20 mM Trisstore calcium and ERK responses, failed to restore JNK
[pH 7.5], and 1 mM EDTA) containing 50 mM NaF, 10 mM sodiumand p38 activation (Figure 6). Together, these results
molybdate, 0.1 mM sodium vanadate, and 0.1 mM pervanadatestrongly suggest that Rac1 activation is defective in
supplemented with protease inhibitors as described previously (Ta-
BLNK-deficient DT40 cells. Indeed, expression of a kata et al., 1994). After centrifugation at 13,000 3 g, supernatant
dominant-negative form of Rac1 in DT40 cells abrogates was precleaned with 5 ml Protein G-Sepharose (Pharmacia) and
the JNK and p38 responses (Hashimoto et al., 1998). then loaded onto a 1 ml of 4G10-Protein G-Sepharose column, which
was washed sequentially with lysis buffer and PBS buffer both con-Previous studies have shown that Vav and SLP-76 coop-
taining 0.1 mM sodium vanadate, 0.1 mM pervanadate, and proteaseerate in augmenting TCR-mediated IL-2 transcription
inhibitors. Phosphotyrosine-containing proteins were eluted with(Wu et al., 1996; Raab et al., 1997) and that BLNK associ-
PBS containing 50 mM phenylphosphate, 0.1 mM sodium vanadate,ates with Vav in activated B cells (Fu and Chan, 1997;
0.1 mM pervanadate, and protease inhibitors. Eluent was passed
Fu et al., 1998; Wienands et al., 1998). Thus, it is most over Sephadex G-25 column (Pharmacia) for desalting and eluted
likely that BLNK is required for Vav activity in B cells. with NP-40 buffer (0.01% NP-40, 10 mM Tris [pH 7.5], and 1 mM
Because tyrosine-phosphorylated Vav is able to cata- EDTA). Proteins were concentrated, subjected to SDS-PAGE gel,
transferred to PVDF membrane (Applied Biosystems), and stainedlyze GDP/GTP exchange activity on Rac1 (Crespo et al.,
with Ponceau S. The band for pp80 was excised and digested with1997), one potential mechanism is that BLNK, like its
Achromobacter protease I and endoproteinase Asp-N. Digestedrole in PLCg2 activation, brings Vav to the proximity of
peptides were chromatographed by reverse-phase HPLC (Wakoactivated Syk, thereby allowing Vav to become phos-
Pure Chemical), and amino acid sequencing was performed with a
phorylated. gas-phase sequencer (Shimadzu, Model PPSQ-23). We obtained
The present findings demonstrate that BLNK func- seven peptide sequences as shown in Figure 1A legends.
tions as a switchboard, allowing PLCg2 and Rac1-JNK
pathways to be turned on. Further selection for PLCg2 Generation of BLNK-Deficient DT40 Cells
A 384 bp BLNK cDNA was cloned by RT-PCR method using RNAor Rac1 might be determined by phosphorylation of
from DT40 B cells. This fragment was then used as a probe fordistinct tyrosine residues within BLNK, because BLNK
screening l ZAP DT40 cDNA library. From 1 x 105 plaques screened,has multiple tyrosine phosphorylation sites. Given that
twenty positive clones were identified and seven clones were further
the fate of B cells depends on which set of signaling characterized. The complete sequence of the longest insert (2417
pathways is connected from the BCR under a given bp encoding protein of 552 amino acids that contains all seven
circumstance (Healy and Goodnow, 1998), it is reason- peptide sequences) has been deposited into GenBank (Accession
No. AF089727). Four genomic clones were obtained by screeningable to anticipate that selection of signaling pathways
l FIXII chicken genomic library (1.3 3 106 plaques) using the sameby BLNK is one of the mechanisms for qualitative regula-
384 bp DNA fragment as a probe. The targeting vectors, pBLNK-tion of BCR signaling, leading to appropriate biological
neo and pBLNK-hisD, were constructed by replacing the genomicresponses.
fragment containing exons that correspond to chicken BLNK amino
acid residues 57±213, with neo and hisD cassettes (Takata et al.,
Experimental Procedures 1994). These cassettes were flanked by 4.4 kb and 2.2 kb of BLNK
genomic sequence on the 59 and 39 side, respectively. Transfectants
Cells and Antibodies were selected in the presence of G418 (2 mg/ml) and clones were
Wild-type and its derivative mutant DT40 cells were cultured in RPMI
screened by Southern blot analysis. The pBLNK-hisD was again
1640 supplemented with 10% fetal calf serum (FCS), 1% chicken
transfected into the neo targeted clone and selected with both G418
serum, 50 mM 2-mercaptoethanol, 2 mM L-glutamine, and antibiot-
(2 mg/ml) and histidiol (1 mg/ml). Introduction of a single copy of
ics. Anti-BLNK Ab or anti-PLCg2 Ab was obtained by immunizing
each targeting vector was verified by reprobing the blots with inter-rabbits with bacterially expressed GST fusion protein containing
nal neo or hisD probe. DT40 cells deficient in PLCg2 or Syk werechicken BLNK (79±201 amino acid region), or chicken PLCg2 that
described previously (Takata et al., 1994, 1995).is corresponding to rat PLCg2 818±919 amino acid region (Emori et
al., 1989), respectively. The anti-chicken IgM Ab, M4 (m, k) (Chen et
Northern Blot Analysisal., 1982), which was used for stimulation of BCR, anti-phosphotyro-
RNA was prepared from wild-type and BLNK-deficient DT40 cellssine Ab (4G10), anti-chicken Lyn Ab, rabbit anti-mouse IgM Ab, anti-
using the guanidium thiocyanate method. Total RNA (20 mg) wasERK2 Ab, anti-p38 Ab, and anti-JNK1 Ab were described previously
separated in 1.2% formaldehyde gel, transferred to Hybond-N1(Takata et al., 1994; Ono et al., 1997; Hashimoto et al., 1998). Anti-
membrane (Amersham), and probed with 32P-labeled chicken cDNAsRas Ab and FITC-conjugated anti-human FcgRIII Ab were purchased
BLNK and b-actin (Kost et al., 1983).from Transduction Laboratories and from Pharmingen, respectively.
Calcium AnalysisExpression Constructs and Transfection
Cells (5 3 106) were suspended in PBS containing 20 mM HEPESHuman H-Ras and chicken BLNK (longer form) cDNAs were cloned
into expression vector pApuro (Takata et al., 1994). The membrane (pH 7.2), 5 mM glucose, 0.025% BSA, and 1 mM CaCl2, and loaded
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with 3 mM Fura-2/AM at 378C for 45 min. Cells were washed twice library, l FIXII chicken genomic library, human H-Ras cDNA,
chicken SLP-76 cDNA, and GST-RBD expression plasmid, respec-and adjusted to 106 cells/ml. For mPLCg2 chimera (Figure 4B), coli-
gation of BCR and the chimera was carried out by adding rabbit tively, and A. Kosugi and M. Gold for advice on the subcellular
analysis and the Ras-GTP assay. This work was supported byanti-mouse IgM (10 mg/ml) followed by anti-chicken IgM MAb, M4
(2 mg/ml). Continuous monitoring of fluorescence from the cell sus- grants to M. I. and T. K. from the Ministry of Education, Science,
Sports, and Culture of Japan, to T. K. from Takeda Science Founda-pension was performed using Hitachi F-2000 fluorescence spectro-
photometer (Hitachi) at an excitation wavelength of 340 nm and tion, and to A. C. C. from the National Institutes of Health
(R01AI42787 and R01CA71516). A. C. C. is also a Pew Scholar inan emission wavelength of 510 nm. Calibration and calculation of
calcium levels were done as described (Grynkiewicz et al., 1985). the Biomedical Sciences.
IP3 Generation Assay Received October 5, 1998; revised December 10, 1998.
Cells (2 3 106) were stimulated with MAb M4 (10 mg) at 378C for
indicated time. Kinetic analysis of IP3 production was performed References
using BIOTRAK IP3 assay system (Amersham) following the manu-
facturer's protocol. Bolland, S., Pearse, R.N., Kurosaki, T., and Ravetch, J.V. (1998). SHIP
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